Holbrook Kerr's Form 4 filing
Avanos Medical, Inc. (AVNS) · filed Nov 19, 2025
- Accession no.
- 0001606498-25-000133
- Filed
- Nov 19, 2025
- Trade date
- Nov 18, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $165.0K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Holbrook KerrCIK 0001861246 | Officer (SVP, Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 18, 2025 | Common Stock | SSaleDisposed | −13,834 | $11.00 | −$152,174 | 85,026 | Direct | |
| Nov 18, 2025 | Common Stock | SSaleDisposed | −100 | $11.01 | −$1,101 | 84,926 | Direct | |
| Nov 18, 2025 | Common Stock | SSaleDisposed | −761 | $11.01 | −$8,378.61 | 84,165 | Direct | |
| Nov 18, 2025 | Common Stock | SSaleDisposed | −305 | $11.02 | −$3,361.1 | 83,860 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.